Literature DB >> 23613343

Mid-term outcomes following endovascular re-intervention for iliac artery in-stent restenosis.

Usman Javed1, Christopher R Balwanz, Ehrin J Armstrong, Khung-Keong Yeo, Gagan D Singh, Satinder Singh, David Anderson, Gregory G Westin, William C Pevec, John R Laird.   

Abstract

OBJECTIVES: We sought to evaluate the procedural characteristics and clinical outcomes of endovascular repair for iliac artery (IA) in-stent restenosis (ISR).
BACKGROUND: An increasing percentage of patients with complex IA occlusive disease are treated with an endovascular approach, but the outcomes of IA-ISR have not been well described.
METHODS: We analyzed all endovascular procedures for treatment of IA-ISR performed at our institution between July 2006-December 2010. The primary outcome was primary patency, defined as <50% stenosis as assessed by clinical examination and duplex ultrasonography (DUS).
RESULTS: Forty-one lesions in 24 patients who underwent repeated endovascular intervention for treatment of IA-ISR. Most lesions were unilateral and involved the common IA (66%). The mean length of ISR was 30.1 ± 14.1 mm with type I (focal) and II (diffuse) ISR occurring with the greatest frequency (34% and 39%, respectively). All patients underwent balloon angioplasty; adjunctive stenting zwas performed in 27 (66%) of the lesions. Type II ISR lesions more frequently required stenting (13/16 lesions, P = 0.02 compared with other patterns of ISR). Procedural success was 100% with a mean gain of 0.13 in the ankle-brachial index (P = 0.001). The 6- and 12-month primary patency rates were 96% and 82%, respectively. The 12-month primary-assisted patency rate was 90% with clinically driven target lesion revascularization (TLR) in three patients.
CONCLUSIONS: Endovascular treatment of IA-ISR using an approach of balloon angioplasty followed by selective stenting is associated with high-patency rates and low rates of TLR at 1 year.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  iliac artery; in-stent restenosis; peripheral arterial disease

Mesh:

Year:  2013        PMID: 23613343      PMCID: PMC3836870          DOI: 10.1002/ccd.24975

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  38 in total

1.  Stent placement in iliac arterial lesions: three years of clinical experience with the Wallstent.

Authors:  D Vorwerk; R W Günther
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

2.  Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial.

Authors:  J C Palmaz; J C Laborde; F J Rivera; C E Encarnacion; J D Lutz; J G Moss
Journal:  Cardiovasc Intervent Radiol       Date:  1992 Sep-Oct       Impact factor: 2.740

3.  Angioplasty and stenting of completely occluded iliac arteries.

Authors:  C R Rees; J C Palmaz; O Garcia; T Roeren; G M Richter; G Gardiner; D Schwarten; R A Schatz; H D Root; W Rogers
Journal:  Radiology       Date:  1989-09       Impact factor: 11.105

4.  Iliac artery stenosis or obstruction after unsuccessful balloon angioplasty: treatment with a self-expandable stent.

Authors:  R W Günther; D Vorwerk; F Antonucci; B Beyssen; A Essinger; J C Gaux; F Joffre; A Raynaud; H Rousseau; C L Zollikofer
Journal:  AJR Am J Roentgenol       Date:  1991-02       Impact factor: 3.959

5.  Reporting standards for lower extremity arterial endovascular procedures. Society for Vascular Surgery/International Society for Cardiovascular Surgery.

Authors:  S S Ahn; R B Rutherford; G J Becker; A J Comerota; K W Johnston; G K McClean; J M Seeger; S T String; R A White; A D Whittemore
Journal:  J Vasc Surg       Date:  1993-06       Impact factor: 4.268

6.  Value of stent placement during percutaneous transluminal angioplasty of the iliac arteries.

Authors:  R Hassen-Khodja; F Sala; S Declemy; P J Bouillanne; M Batt; P Staccini
Journal:  J Cardiovasc Surg (Torino)       Date:  2001-06       Impact factor: 1.888

7.  External iliac and common iliac artery angioplasty and stenting in men and women.

Authors:  C H Timaran; S L Stevens; M B Freeman; M H Goldman
Journal:  J Vasc Surg       Date:  2001-09       Impact factor: 4.268

8.  Long-term results 10 years after iliac arterial stent placement.

Authors:  Karl Schürmann; Andreas Mahnken; Julius Meyer; Patrick Haage; Khaled Chalabi; Ilse Peters; Rolf W Günther; Dierk Vorwerk
Journal:  Radiology       Date:  2002-09       Impact factor: 11.105

9.  Iliac arteries: reanalysis of results of balloon angioplasty.

Authors:  K W Johnston
Journal:  Radiology       Date:  1993-01       Impact factor: 11.105

10.  Aortoiliac insufficiency: long-term experience with stent placement for treatment.

Authors:  Timothy P Murphy; Nikki S Ariaratnam; Wilfred I Carney; Edward J Marcaccio; Jeffrey M Slaiby; Gregory M Soares; H Myra Kim
Journal:  Radiology       Date:  2004-02-19       Impact factor: 11.105

View more
  4 in total

1.  Endovascular approach to iliac artery stenosis and restenosis.

Authors:  Gurjaipal Kang
Journal:  Indian Heart J       Date:  2015-10-30

2.  SCAI guidelines on device selection in Aorto-Iliac arterial interventions.

Authors:  Dmitriy N Feldman; Ehrin J Armstrong; Herbert D Aronow; Subhash Banerjee; Larry J Díaz-Sandoval; Michael R Jaff; Sasanka Jayasuriya; Safi U Khan; Andrew J Klein; Sahil A Parikh; Kenneth Rosenfield; Mehdi H Shishehbor; Rajesh V Swaminathan; Christopher J White
Journal:  Catheter Cardiovasc Interv       Date:  2020-05-14       Impact factor: 2.692

3.  The association between periprocedural factors and the late outcome of percutaneous stenting of lower extremity arteries. A retrospective cohort study.

Authors:  Paweł Grzelązka; Klaudia Koza; Adrianna Trofimiuk; Karol Suppan; Marcin Wasielewski; Joanna Wiśniewska; Jacek Budzyński
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-06-22       Impact factor: 1.426

Review 4.  Endovascular revascularization for aortoiliac atherosclerotic disease.

Authors:  Vikas Aggarwal; Stephen W Waldo; Ehrin J Armstrong
Journal:  Vasc Health Risk Manag       Date:  2016-03-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.